Multimodal therapy of Miller Fisher syndrome. The possible benefit of CSF-filtration;Multimodale therapie eines Miller-Fisher-syndroms. Der mogliche nutzen der liquor-cerebrospinalis-filtration

Nervenarzt

Volumn 68, Issue 12, 1997, Pages 1002-1003

  Pfausler, B ^a   Grubwieser, G ^a   Auckenthaler, A ^a   Rogenhofer, H ^a   Schmutzhard, E ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

CSF filtration; Miller Fisher syndrome

Indexed keywords

IMMUNOGLOBULIN;

ADULT; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID; DRUG MEGADOSE; FILTRATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PLASMAPHERESIS; SUBCLAVIAN STEAL SYNDROME; TREATMENT OUTCOME;

FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; MILLER FISHER SYNDROME; NEUROLOGIC EXAMINATION; PLASMAPHERESIS; TREATMENT FAILURE; ULTRAFILTRATION;

EID: 0031466265     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001150050230     Document Type: Article

References (19)

1. + channel blocking factor in the cerebrospinal fluid. Eur J Physiol 421:552-557
2. Compton DAS, Morgan BP, Oleesky D, Fifield R, Campbell AK (1986) Cerebrospinal fluid C9 in demyelinating diseases. Neurology 36:1503-1506
3. Fisher M (1956) An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med 255:57-65
4. French Cooperative Group on Plasma Exchange in Guillain-Barrè Syndrome (1987) Efficiency of plasma exchange in Guillain-Barrè syndrome: role of replacement fluids. Ann Neurol 22:753-61
5. Guillain-Barrè Syndrome Study Group (1985) Plasmapheresis and acute Guillain-Barrè syndrome. Neurology 35:1096-104
6. Hartung HP, Jung ST, Stoll G, Zielasek J, Schmidt B, Archelos JJ, Toyka KV (1992) Inflammatory mediators in demyelinating disorders of the CNS and PNS. J Neuroimmunol 40:197-210
7. Hartung HP, Schwenke CH, Bitter-Suermann D, Toyka KV (1987) Guillain-Barrè-syndrome: activated complement components C3a and C5a in CSF. Neurology 37:1006-1009
8. Petty RKH, Duncan R, Jamal GA, Hadley D, Kennedy PGE (1993) Brainstem encephalitis and the Miller Fisher syndrome. J Neurol Neurosurg Psychiatry 56:201-203
9. Ropper AH (1992) The Guillain Barrè syndrome. N Engl J Med 326:1130-1136
10. Sanders ME, Koski CL, Robbins D, Shin ML, Frank MM Joiner KA (1986) Activated terminal complement in cerebrospinal fluid in Guillain-Barrè-syndrome and multiple sclerosis. J Immunol 136:4456-4459
11. Sharif MK, McLean B, Thompson EJ (1993) Elevated serum levels of tumor necrosis factor alpha in Guillain-Barrè-Syndrome. Ann Neurol 33:591-596
12. Simone JL, Annunziata P, Maimone D, Liguori M, Leante R, Livrea P (1993) Serum and CSF anti GM1 antibodies in patients with Guillain-Barrè syndrome and chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 114:49-55
13. Tibbling G, Link H,Öhman S (1977) Principles of albumin and IgG analysis in neurological disorders I. Establishment of reference values. Scand J Clin Lab Invest 37:385-390
14. Trotter J, Smith ME (1986) The role of phospholipases from inflammatory macrophages in demyelination. Neurochem Res 11:349-361
15. van der Mechè FGA, Schmitz PIM, Dutch Guillain-Barrè Study Group (1992) A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barrè syndrome. N Engl J Med 326:1123-1129
16. Weller M, Stevens A, Sommer N, Melms A, Dichgans J, Wiethölter H (1991) Comparative analysis of cytokine patterns in immunological, infectious and oncological neurological disorders. J Neurol Sci 104:215-221
17. Wollinsky KH, Hulser PJ, Manch E, Mehrkens HH, Kornhuber HH (1992) Liquorpherese bei 10 Patienten mit Multipler Sklerose. In: Schimrigk K, Haaß A, Hamann G (Hrsg) Verhandlungen der Deutschen Gesellschaft für Neurologie, 7, Opththalmoneurologie-Therapiekontrolle - Pravention, S 44-45
18. Wollinsky KH, Hülser PJ, Westarp ME, Mehrkens HH, Kornhuber HH (1992) Cerebrospinal fluid "pheresis" in Guillain Barrè syndrome. Med Hypoth 38:155-165
19. Wollinsky KH, Weindler M, Hülser PJ, Geiger P, Matzek N, Mehrkens HH, Kornhuber HH (1991) Liquor-pheresis (CSF-Filtration):an effective treatment in acute and chronic severe autoimmune polyradiculoneuritis (Guillain-Barrè-Syndrome). Eur Arch Psych Clin Neurosci 241:73-76